Diwakar D. Balachandran

Diwakar D. Balachandran

Auto-generated profile, based on publicly available information

Diwakar D. Balachandran

Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2000 in Chest
Verified
Journal Article
Closed access
NMNaresh G. Mansharamani
Naresh G. Mansharamani
DBDiwakar Balachandran
Diwakar Balachandran
IVInna Vernovsky
Inna Vernovsky
RGRobert Garland
Robert Garland
HKHenry Koziel
Henry Koziel

1 May 2014 in Thyroid®
Verified
Journal Article
Closed access
DBDean P. Blevins
Dean P. Blevins
RDRamona Dadu
Ramona Dadu
MHMimi Hu
Mimi Hu
CBChristina Baik
Christina Baik
DBDiwakar Balachandran
Diwakar Balachandran
MCMaria E. Cabanillas
Maria E. Cabanillas
Background: In the past decade, targeted therapy with antiangiogenic drugs has become standard of care for most types of metastatic, progressive thyroid cancer. While these drugs were thought initially to be less toxic than traditional chemotherapy, they can have rare but serious and fatal toxicities. Once such toxicity that has been reported in other tumor types is upper airway fistula formation, which can be life-threatening. Summary: Here, we describe three patients treated with antiangiogenic tyrosine kinase inhibitors at two academic institutions who developed aerodigestive fistula. All three patients had risk factors for fistula formation, which included external beam radiation and/or large tumor with invasion of the tracheal wall. Conclusions: Fistula formation is a known but rare side effect of antiangiogenic tyrosine kinase inhibitors. Knowledge of the risk factors that may predispose thyroid cancer patients to this serious adverse event is vital prior to prescribing antiangiogenics. Particular caution should be observed when using these drugs in patients undergoing radiation therapy or surgery, or in patients whose tumor is invading vital structures of the neck, as they may be at higher risk of developing this rare complication. In these patients, antiangiogenic tyrosine kinase inhibitors should be used cautiously, patients should be aware of the risk, and physicians should monitor patients for symptoms of fistula.

1 December 2009 in Surgery
Verified
Journal Article
Closed access
NPNancy D. Perrier
Nancy D. Perrier
DBDave Balachandran
Dave Balachandran
JWJeffrey S. Wefel
Jeffrey S. Wefel
CJCamilo Jimenez
Camilo Jimenez
NBNaifa Busaidy
Naifa Busaidy
JLJeffrey E. Lee
Jeffrey E. Lee

17 April 2006 in Journal of Experimental Medicine
Verified
Journal Article
Open access
JTJiankun Tong
Jiankun Tong
HBHozefa S. Bandulwala
Hozefa S. Bandulwala
BCBryan S. Clay
Bryan S. Clay
RARobert A. Anders
Robert A. Anders
RSRebecca A. Shilling
Rebecca A. Shilling
ASAnne I. Sperling
Anne I. Sperling
Persistent airway inflammation, mucus production, and airway hyperreactivity are the major contributors to the frequency and severity of asthma. Why lung inflammation persists in asthmatics remains unclear. It has been proposed that Fas-mediated apoptosis of inflammatory cells is a fundamental mechanism involved in the resolution of eosinophilic airway inflammation. Because infiltrating eosinophils are highly sensitive to Fas-mediated apoptosis, it has been presumed that direct ligation of Fas on eosinophils is involved. Here, we utilize adoptive transfers of T cells to demonstrate that the delayed resolution of eosinophilia in Fas-deficient mice is a downstream effect of Fas deficiency on T cells, not eosinophils. Interestingly, the mice that received Fas-deficient T cells, but not the controls, developed a persistent phase of inflammation that failed to resolve even 6 wk after the last challenge. This persistent phase correlated with decreased interferon (IFN)γ production by Fas-deficient T cells and could be reproduced with adoptive transfer of IFNγ-deficient T cells. These data demonstrate that Fas deficiency on T cells is sufficient for the development of long-term allergic airway disease in mice and implies that deregulation of death receptors such as Fas on human T cells could be an important factor in the development and/or chronic nature of asthma.

1 June 2014 in Chest
Verified
Journal Article
Closed access
DODavid Ost
David Ost
CJCarlos A. Jimenez
Carlos A. Jimenez
XLXiudong Lei
Xiudong Lei
SCScott B. Cantor
Scott B. Cantor
HGHoriana B. Grosu
Horiana B. Grosu
GEGeorge A. Eapen
George A. Eapen

1 October 2014 in The Oncologist
Verified
Journal Article
Closed access
PDF file
SFSaadia A. Faiz
Saadia A. Faiz
DBDiwakar Balachandran
Diwakar Balachandran
AHAmy C. Hessel
Amy C. Hessel
XLXiudong Lei
Xiudong Lei
BBBeth M. Beadle
Beth M. Beadle
LBLara Bashoura
Lara Bashoura
Background.: Sleep disturbance is a prominent complaint of cancer patients. Most studies have focused on insomnia and cancer-related fatigue. Obstructive sleep apnea (OSA) has been reported in small studies and case reports. Methods.: In a retrospective review of patients who underwent formal sleep evaluation and polysomnography (PSG) from 2006 to 2011, 56 patients with tumors in the head and neck region were identified. Clinical characteristics, sleep-related history, and PSG data were reviewed. Results.: Most patients had active cancer (80%), and the majority had squamous pathology (68%). Prominent symptoms included daytime fatigue (93%), daytime sleepiness (89%), and snoring (82%). Comorbid conditions primarily included hypertension (46%) and hypothyroidism (34%). Significant sleep-related breathing disorder was noted in 93% of patients, and 84% met clinical criteria for OSA. A male predominance (77%) was noted, and patients were not obese (body mass index <30 kg/m2 in 52%). The majority of patients (79%) underwent radiation prior to sleep study, of which 88% had OSA, and in the group without prior radiation, 67% had OSA. Adherence to positive airway pressure (PAP) therapy was slightly better when compared with the general population. A subset of patients with persistent hypoxia despite advanced forms of PAP required tracheostomy. Multivariate analysis revealed that patients with active disease and radiation prior to PSG were more likely to have OSA. Conclusion.: Sleep-related breathing disorder was common in patients with tumors in the head and neck region referred for evaluation of sleep disruption, and most met clinical criteria for OSA. Daytime fatigue and sleepiness were the most common complaints. OSA was prevalent in male patients, and most with OSA were not obese. Architectural distortion from the malignancy and/or treatment may predispose these patients to OSA by altering anatomic and neural factors. A heightened clinical suspicion for sleep-related breathing disorder and referral to a sleep specialist would be beneficial for patients with these complaints.